BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33011454)

  • 1. Genome editing systems across yeast species.
    Yang Z; Blenner M
    Curr Opin Biotechnol; 2020 Dec; 66():255-266. PubMed ID: 33011454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in gene editing technologies for Saccharomyces cerevisiae].
    Li H; Liang X; Zhou J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):950-965. PubMed ID: 33783160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for Multiplexed Integration of Synergistic Alleles and Metabolic Pathways in Yeasts via CRISPR-Cas9.
    Walter JM; Schubert MG; Kung SH; Hawkins K; Platt DM; Hernday AD; Mahatdejkul-Meadows T; Szeto W; Chandran SS; Newman JD; Horwitz AA
    Methods Mol Biol; 2019; 2049():39-72. PubMed ID: 31602604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of CRISPR/Cas gene-editing technology in yeast and fungi.
    Liao B; Chen X; Zhou X; Zhou Y; Shi Y; Ye X; Liao M; Zhou Z; Cheng L; Ren B
    Arch Microbiol; 2021 Dec; 204(1):79. PubMed ID: 34954815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Genome Engineering Methods for Yeast Cell Factory Development.
    Malcı K; Walls LE; Rios-Solis L
    Front Bioeng Biotechnol; 2020; 8():589468. PubMed ID: 33195154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in the application of multiplex genome editing in Saccharomyces cerevisiae.
    Zhang ZX; Wang LR; Xu YS; Jiang WT; Shi TQ; Sun XM; Huang H
    Appl Microbiol Biotechnol; 2021 May; 105(10):3873-3882. PubMed ID: 33907890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple-to-use CRISPR-SpCas9/SaCas9/AsCas12a vector series for genome editing in Saccharomyces cerevisiae.
    Okada S; Doi G; Nakagawa S; Kusumoto E; Ito T
    G3 (Bethesda); 2021 Dec; 11(12):. PubMed ID: 34739076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas Technology for Bioengineering Conventional and Non-Conventional Yeasts: Progress and New Challenges.
    Xia Y; Li Y; Shen W; Yang H; Chen X
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-copy genome integration of 2,3-butanediol biosynthesis pathway in Saccharomyces cerevisiae via in vivo DNA assembly and replicative CRISPR-Cas9 mediated delta integration.
    Huang S; Geng A
    J Biotechnol; 2020 Feb; 310():13-20. PubMed ID: 32006629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Gene Editing and Metabolic Regulation of
    Liang Y; Gao S; Qi X; Valentovich LN; An Y
    ACS Synth Biol; 2024 Feb; 13(2):428-448. PubMed ID: 38326929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae.
    Generoso WC; Gottardi M; Oreb M; Boles E
    J Microbiol Methods; 2016 Aug; 127():203-205. PubMed ID: 27327211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of genome editing in yeast.
    Fraczek MG; Naseeb S; Delneri D
    Yeast; 2018 May; 35(5):361-368. PubMed ID: 29345746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
    Giersch RM; Finnigan GC
    Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Cas9-VPR Nuclease for Simultaneous Gene Activation, Repression, and Editing in
    Dong C; Jiang L; Xu S; Huang L; Cai J; Lian J; Xu Z
    ACS Synth Biol; 2020 Sep; 9(9):2252-2257. PubMed ID: 32841560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACtivE: Assembly and CRISPR-Targeted
    Malcı K; Jonguitud-Borrego N; van der Straten Waillet H; Puodžiu Naitė U; Johnston EJ; Rosser SJ; Rios-Solis L
    ACS Synth Biol; 2022 Nov; 11(11):3629-3643. PubMed ID: 36252276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMI: CRISPR/Cas9 Based Efficient Multiplexed Integration in
    Meng J; Qiu Y; Zhang Y; Zhao H; Shi S
    ACS Synth Biol; 2023 May; 12(5):1408-1414. PubMed ID: 36853024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.